Clinical Trial Update: Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer：MetBio-CRC

View source ↗

Summary

This clinical trial aims to develop and validate metabolic biomarkers for early diagnosis, prognosis, and recurrence monitoring in colorectal cancer. Recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Shanghai Minimally Invasive Surgery Center | Conditions: Colorectal Cancer | Status: RECRUITING